return equiti ttm
post-cal model adjust significantli lower ep
estim reflect cordi turmoil
updat model follow thursday morn releas
fiscal third-quart earn recal compani miss target cent
quarter given cordi write-off relat spike tax rate decreas fiscal
adjust ep target midpoint compani
updat guidanc addit decreas fiscal ep estim
follow initi cautionari commentari manag
although macro environ appear stabil cardin core drug
distribut busi consist recent comment peer amerisourcebergen
manag note headwind come year
number contract renew slightli wors gener deflat much significantli
cardin new leadership took opportun acknowledg signific challeng
cordi busi acquir integr asset persist lag
expect manag discuss outlook appear get wors
instead better appar take anoth year get control given
compani global tax plan structur larg cost issu cordi also drive
corpor tax rate result fiscal like third consecut
year littl earn growth cardin larg reset cordi also call
question compani broader strategi medic segmentth recipi
billion dollar capit deploy last decad given stock correct
roughli compar reduct earn estim next year
maintain market perform rate stock
pharmaceut segment pharmaceut segment revenu
quarter estim oper incom prior year
much less expect declin compar declin
estim core drug distribut busi appear stabil red oak
specialti busi reportedli grow nice manag acknowledg
expect slightli higher gener deflat mid- high singl digit note
number loom contract renew like result downward price
result mix bag improv incom assumpt pharma segment
fiscal instead previous lower incom
expect next year declin instead declin previous thu
pharma appear stabl still growth busi
one largest healthcar distributor unit state canada strong market
share posit pharmaceut medic product distribut market cardin one three largest
player pharmaceut distribut market signific distributor medic consum suppli
hospit physician offic altern care site
pleas refer import disclosur page analyst certif page
william blair affili seek busi compani cover research report
result investor awar firm may conflict interest could affect object
report report intend provid person invest advic opinion recommend
herein take account individu client circumst object need intend
recommend particular secur financi instrument strategi particular client recipi
report must make independ decis regard secur financi instrument mention
medic segment medic segment significantli miss expect fiscal third quarter revenu
compar estim oper incom thank patient recoveri asset
purchas well growth target manag indic virtual
under-perform due on-going inventori write-off cordi busi particularli intern
oper surprisingli appear inventory-driven cost overrun could persist year given
cordi problem expect investor much skeptic accret potenti recent ad patient
recoveri busi well futur purchas medic segment model medic deliv incom growth
fiscal prior target growth
note lower fiscal adjust ep estim model top-lin growth
consolid revenu growth previous result top-lin out-performance quarter
pharmaceut segment increas organ growth estim medic segment
reduc organ growth estim lower ebit margin basi point
model fiscal consolid revenu billion billion lower oper
margin
lower fiscal ep estim decreas revenu growth estim
given lower expect medic busi primarili cordi lower oper margin
valuat stock thought
thursday close follow declin trade time updat calendar ep
estim four turn five-year averag slightli peer group averag
maintain market perform rate despit sign stabil drug distribut await
sign medic segment becom consist organ contributor growth updat model segment
assumpt follow exhibit
good gross oper interest expens pre-tax incom tax net incom excl nonrecur item net earn attribut non-controlling incom cardin excl nonrecur excl tax item net net incom includ nonrec discontinu operationsnet incom includ nonrec discontinu ep excl non-recurring item amort begin fy excl non-recurring item includ incl nonrec item amort excl non-recurring item amort beg averag share outstand analysi gross incom incom rate total incom incom excl non-recurring includ excl non-recurring amort beg fy share blair compani estimatesourc compani report william blair compani llc estim william blair
y/i metro growthorgan y/i growth profit million adjust amort begin fy y/i segment total oper y/i patient y/i growth profit million adjust amort begin fy y/i segment oper profit blair compani estimatesourc compani report william blair compani llc estim import disclosur
